Clinical Trial

A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo

Study acronym: GOBO 2
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a randomised, double-blind, parallel, placebo-controlled study in healthy adults to compare the absorption of two microalgal formulations, to a fish oil and a placebo. Participant will take their assigned study product for 6 weeks and attend the clinic for 4 visits.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-03
Trial Details
NCT Number NCT07241377
Lead Sponsor RDC Clinical Pty Ltd
Collaborators: DSM-Firmenich AG
Conditions Absorption of Omega-3, Omega-3 Supplementation, Healthy Participants
Enrollment 120 participants
Start Date 2025-10-27
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02